Elanco Animal Health Inc

NYSE:ELANHealthcareNASDAQ:NQUSMGSTOXX:EDD24BP

$23.49−0.25%At closeAt close · Tue 20 Oct · ≈ AED 86.27 · Market cap $11.74B · Next earnings Wed 4 Nov · Extended $22.99 −2.13%

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	3.3	4.8	4.4	4.4	4.4	4.7	5.0	+6.5%
Cost of revenue	2.0	2.7	2.4	2.5	2.5	2.7	2.2	−15.9%
Gross profit	1.2	2.1	2.0	1.9	1.9	2.1	2.8	+35.6%
Research & development	0.3	0.4	0.3	0.3	0.3	0.4	0.4	+0.8%
Selling, general & administrative	1.0	1.4	1.3	1.3	1.3	1.4	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.2	0.0	—	—
Operating expenses	1.3	1.8	1.6	1.6	1.7	1.8	—	—
Operating income	(0.1)	0.3	0.4	0.3	0.3	0.3	0.5	+86.9%
Interest expense	0.2	0.3	0.3	0.3	0.3	0.2	0.3	+31.4%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other income / expense	(0.6)	(0.9)	(0.5)	(1.5)	0.2	(0.5)	—	—
Pre-tax income	(0.7)	(0.6)	(0.1)	(1.2)	0.5	(0.2)	(0.2)	+25.9%
Income tax	(0.1)	(0.1)	0.0	0.0	0.2	0.0	0.0	+312.5%
Net income	(0.6)	(0.5)	(0.1)	(1.2)	0.3	(0.2)	(0.2)	+14.2%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	(1.27)	(0.97)	(0.15)	(2.50)	0.68	(0.47)	(0.41)	+13.7%
EPS, diluted (per share)	(1.27)	(0.97)	(0.15)	(2.50)	0.68	(0.47)	(0.41)	+13.7%
EBITDA	0.0	0.4	0.9	(0.2)	1.5	0.7	1.0	+48.1%
Depreciation & amortization	0.5	0.7	0.7	0.7	0.7	0.7	0.7	+1.9%
Weighted average shares (shares)	441,400,000	487,200,000	488,300,000	492,300,000	494,000,000	496,400,000	—	—
Weighted average diluted shares (shares)	441,400,000	487,200,000	488,300,000	492,300,000	497,300,000	496,400,000	—	—
Gross margin	38.1%	43.6%	44.7%	43.9%	43.0%	43.5%	55.4%	+11.9 pts
Operating margin	−2.3%	6.4%	8.7%	7.4%	5.7%	5.3%	9.4%	+4.0 pts
Net margin	−17.1%	−10.1%	−1.8%	−27.9%	7.6%	−4.9%	−4.0%	+1.0 pts